IDEXX LABORATORIES INC /DE

IDXX

$44.34B

Large Cap

NASDAQIn Vitro & In Vivo Diagnostic Substances🇺🇸North AmericaWESTBROOK

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

IDXX News

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

How IDXX's past catalysts played out

earningsNov 2025+15%earningsAug 2025+27%earningsMay 2025+9%earningsOct 2024-10%earningsMay 2024-5%earningsNov 2022+10%earningsMay 2022-6%earningsNov 2021-6%

Drug Pipeline

No drugs found in this phase.

📑

Catalyst DossierPRO

The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.

→

Market-Implied Move

Regulatory Approvals

Frequently asked questions

When is IDEXX LABORATORIES INC /DE's next FDA catalyst?→

CatalystAlert tracks every upcoming catalyst for IDEXX LABORATORIES INC /DE (IDXX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track IDXX biotech catalysts?→

Add IDXX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow IDEXX LABORATORIES INC /DE's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply